ARV-1801

· Arrevus Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARV-1801, covering 2024-02-16 to 2024-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients [Phase 2]

See pricing